Literature DB >> 34182612

Predicted N-terminal N-linked glycosylation sites may underlie membrane protein expression patterns in Saccharomyces cerevisiae.

Rashmi Karki1, Swechha Rimal2, Monica D Rieth2.   

Abstract

N-linked glycosylation is one type of posttranslational modification that proteins undergo during expression. The following describes the effects of N-linked glycosylation on high-level membrane protein expression in yeast with an emphasis on Saccharomyces cerevisiae. N-linked glycosylation is highlighted here as an important consideration when preparing membrane protein gene constructs for expression in S. cerevisiae, which continues to be used as a workhorse in both research and industrial applications. Non-native N-linked glycosylation commonly occurs during the heterologous expression of mammalian proteins in many yeast species which can have important immunological consequences when used in the production of biotherapeutic proteins or peptides. Further, non-native N-linked glycosylation can lead to improper protein folding and premature degradation, which can impede high-level expression yields and hinder downstream analysis. Multiple strategies are presented in this article, which suggest different methods that can be implemented to circumvent the unwanted consequences of N-linked glycosylation during the expression process. These considerations may have long-term benefits for high-level protein production in S. cerevisiae across a broad spectrum of expression targets with special emphasis placed on G-protein coupled receptors, one of the largest families of membrane proteins.
© 2021 John Wiley & Sons, Ltd.

Entities:  

Keywords:  G-protein coupled receptors; N-linked glycosylation; Saccharomyces cerevisiae; expression; membrane proteins; post-translational modifications

Mesh:

Substances:

Year:  2021        PMID: 34182612     DOI: 10.1002/yea.3657

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  2 in total

1.  Nascent Glycoproteome Reveals That N-Linked Glycosylation Inhibitor-1 Suppresses Expression of Glycosylated Lysosome-Associated Membrane Protein-2.

Authors:  Xinyi Cao; Peiyi Meng; Yuyin Shao; Guoquan Yan; Jun Yao; Xinwen Zhou; Chao Liu; Lei Zhang; Hong Shu; Haojie Lu
Journal:  Front Mol Biosci       Date:  2022-04-27

2.  The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation.

Authors:  Dina Baier; Beatrix Schoenhacker-Alte; Mate Rusz; Christine Pirker; Thomas Mohr; Theresa Mendrina; Dominik Kirchhofer; Samuel M Meier-Menches; Katharina Hohenwallner; Martin Schaier; Evelyn Rampler; Gunda Koellensperger; Petra Heffeter; Bernhard Keppler; Walter Berger
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.